Form 4: CTM COO Andrew Merriman awarded 275,000 options at $1.19
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Castellum (CTM) reported an insider equity grant. Chief Operating Officer Andrew Merriman was awarded 275,000 stock options on November 11, 2025 under the Second Amended 2021 Stock Incentive Plan at an exercise price of $1.19 per share. The options vest ratably over twenty months, beginning December 1, 2025, and expire on November 10, 2032. Following the grant, 275,000 derivative securities are beneficially owned directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Merriman Andrew
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options | 275,000 | $0.00 | -- |
Holdings After Transaction:
Stock Options — 275,000 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did Castellum (CTM) disclose in this Form 4?
The COO, Andrew Merriman, received 275,000 stock options on November 11, 2025 at an exercise price of $1.19.
What is the vesting schedule for the CTM COO’s options?
They vest ratably over twenty months, starting December 1, 2025.
What is the exercise price and expiration for the options?
The exercise price is $1.19 per share; the options expire on November 10, 2032.
How many derivative securities does the COO own after the transaction?
Following the grant, 275,000 derivative securities are beneficially owned directly.
Under which plan were the options granted to CTM’s COO?
They were issued under the Castellum, Inc. Second Amended 2021 Stock Incentive Plan.
Who is the reporting person in this CTM Form 4 filing?
The reporting person is Andrew Merriman, Chief Operating Officer of Castellum, Inc.